These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10353549)

  • 1. Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma.
    Nguyen HH; Proye CA; Carnaille B; Combemale F; Pattou FN; Huglo D
    Aust N Z J Surg; 1999 May; 69(5):350-3. PubMed ID: 10353549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
    Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
    Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
    van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
    J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
    Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
    J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
    Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
    Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.
    Khafagi FA; Shapiro B; Fischer M; Sisson JC; Hutchinson R; Beierwaltes WH
    Eur J Nucl Med; 1991; 18(3):191-8. PubMed ID: 1645665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
    Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F
    Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
    Bhatia KS; Ismail MM; Sahdev A; Rockall AG; Hogarth K; Canizales A; Avril N; Monson JP; Grossman AB; Reznek RH
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):181-8. PubMed ID: 18394016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.
    Koizumi M; Endo K; Sakahara H; Nakashima T; Nakano Y; Nakao K; Torizuka K
    Acta Radiol Diagn (Stockh); 1986; 27(3):305-9. PubMed ID: 3751679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
    J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomas.
    Sinclair AJ; Bomanji J; Harris P; Ross G; Besser GM; Britton KE
    Nucl Med Commun; 1989 Aug; 10(8):567-76. PubMed ID: 2812639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.
    Campeau RJ; Garcia OM; Correa OA; Rege AB
    South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET in the evaluation of phaeochromocytoma: a correlative study with MIBG scintigraphy and Ki-67 proliferative index.
    Lin M; Wong V; Yap J; Jin R; Leong P; Campbell P
    Clin Imaging; 2013; 37(6):1084-8. PubMed ID: 24035263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis.
    Van Der Horst-Schrivers AN; Jager PL; Boezen HM; Schouten JP; Kema IP; Links TP
    Anticancer Res; 2006; 26(2B):1599-604. PubMed ID: 16619578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma.
    Gedik GK; Hoefnagel CA; Bais E; Olmos RA
    Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):725-33. PubMed ID: 18071700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.